| Pharmacology: Pharmacodynamics: Gliclazide reduces blood glucose by stimulating insulin secretion from the βcells in the islets of Langerhans. In type 2 diabetics, gliclazide restores the first peak of insulin secretion in response to glucose and increases the second phase of insulin secretion. A significant increase in insulin response is seen in response to stimulation induced by a meal or glucose. |